Check Cap Ltd (NASDAQ:CHEK)’s share price fell 25.7% on Monday . The stock traded as low as $2.21 and last traded at $2.25, with a volume of 1,357,053 shares trading hands. The stock had previously closed at $3.03.

Several brokerages recently weighed in on CHEK. Zacks Investment Research lowered shares of Check Cap from a “buy” rating to a “hold” rating in a research report on Wednesday, July 20th. Maxim Group lifted their price target on shares of Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a research report on Monday, August 1st. Finally, Chardan Capital dropped their price target on shares of Check Cap from $6.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, May 20th.

The stock’s market cap is $30.01 million. The company’s 50-day moving average price is $1.36 and its 200-day moving average price is $2.23.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.